G
Giovanni F.M. Strippoli
Researcher at University of Sydney
Publications - 318
Citations - 19179
Giovanni F.M. Strippoli is an academic researcher from University of Sydney. The author has contributed to research in topics: Kidney disease & Population. The author has an hindex of 71, co-authored 298 publications receiving 16385 citations. Previous affiliations of Giovanni F.M. Strippoli include University of Catania & University of Eastern Piedmont.
Papers
More filters
Journal ArticleDOI
Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
Monica Franciosi,Giuseppe Lucisano,Emanuela Lapice,Giovanni F.M. Strippoli,Fabio Pellegrini,Antonio Nicolucci +5 more
TL;DR: Results suggest that Metformin might be associated with a significant reduction in the risk of cancer and cancer-related mortality, and randomized trials specifically designed to evaluate the efficacy of metformin as an anticancer agent are warranted.
Journal ArticleDOI
Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials
Giorgia De Berardis,Michele Sacco,Giovanni F.M. Strippoli,Fabio Pellegrini,Giusi Graziano,Gianni Tognoni,Antonio Nicolucci +6 more
TL;DR: A clear benefit of aspirin in the primary prevention of major cardiovascular events in people with diabetes remains unproved and sex may be an important effect modifier.
Journal ArticleDOI
Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review
Giovanni F.M. Strippoli,Maria E. Craig,Jonathan J Deeks,Francesco Paolo Schena,Jonathan C. Craig +4 more
TL;DR: Although the survival benefits of ACE inhibitors for patients with diabetic nephropathy are known, the relative effects ofACE inhibitors and AIIRAs on survival are unknown owing to the lack of adequate head to head trials.
Journal ArticleDOI
Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials.
Elisabeth M Hodson,Cheryl A Jones,Cheryl A Jones,Angela C Webster,Angela C Webster,Giovanni F.M. Strippoli,Giovanni F.M. Strippoli,Peter Barclay,Kathy Kable,Dushyanthi Vimalachandra,Jonathan C. Craig,Jonathan C. Craig +11 more
TL;DR: Prophylaxis with antiviral medications reduces the risk of cytomegalovirus disease and associated mortality in recipients of solid-organ transplants and should be used routinely in cytomeGalovirus-positive recipients and in cytomesgalov virus-negative recipients of organs positive for the virus.
Journal ArticleDOI
Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis.
Suetonia C. Palmer,Dimitris Mavridis,Dimitris Mavridis,Antonio Nicolucci,David W. Johnson,David W. Johnson,Marcello Tonelli,Jonathan C. Craig,Jasjot K. Maggo,Vanessa Gray,Giorgia De Berardis,Marinella Ruospo,Patrizia Natale,Valeria Saglimbene,Sunil V. Badve,Sunil V. Badve,Yeoungjee Cho,Annie-Claire Nadeau-Fredette,Michael Burke,Michael Burke,Labib Faruque,Anita Lloyd,Nasreen Ahmad,Yuanchen Liu,Sophanny Tiv,Natasha Wiebe,Giovanni F.M. Strippoli,Giovanni F.M. Strippoli +27 more
TL;DR: Findings are consistent with American Diabetes Association recommendations for using metformin monotherapy as initial treatment for patients with type 2 diabetes and selection of additional therapies based on patient-specific considerations.